Canadian Cardiovascular Society atrial fibrillation Guidelines 2010: Prevention and treatment of atrial fibrillation following cardiac surgery

Canadian Journal of Cardiology

Volumn 27, Issue 1, 2011, Pages 91-97

  Mitchell, L Brent ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MAGNESIUM SULFATE; METOPROLOL; SOTALOL; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT;

ANTICOAGULATION; ANXIETY; ARTICLE; ATRIOVENTRICULAR BLOCK; BRONCHOSPASM; CARDIOVASCULAR RISK; COGNITIVE DEFECT; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ATRIUM PACING; HEART HEMODYNAMICS; HEART SURGERY; HOSPITALIZATION; HUMAN; HYPOTENSION; INCIDENCE; INTENSIVE CARE UNIT; LUNG TOXICITY; PRACTICE GUIDELINE; RESPIRATION DEPRESSION; SEDATION; SIDE EFFECT; SINUS BRADYCARDIA; STROKE; TORSADE DES POINTES; CANADA; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DRUG COMBINATION; DRUG CONTRAINDICATION; EVIDENCE BASED MEDICINE; HEART DISEASE; HEART PACING; LENGTH OF STAY; POSTOPERATIVE COMPLICATION; PREMEDICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR;

ADRENERGIC BETA-ANTAGONISTS; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CANADA; CARDIAC PACING, ARTIFICIAL; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; HEART DISEASES; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MAGNESIUM SULFATE; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 79953310395     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2010.11.005     Document Type: Article

References (46)

1. Andrews TC, Reinmold SC, Berlin JA, Antman EM. Prevention of supraven-tricular arrhythmias after coronary artery bypass surgery: a meta-analysis of randomized control trials. Circulation 1991;84:III-236-44.
2. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993;56:539-49.
3. Fuller JA, Adams GG, Buxton B. Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly? J Thorac Cardiovasc Surg 1989;97:821-5.
4. Leitch JW, Thomson D, Baird DK, Harris PJ. The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1990;100:338-42.
5. Crosby LH, Pifalo WB, Woll KR, Burkholder JA. Risk factors for atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 1990;66: 1520-2.
6. Hashimoto K, Ilstrup DM, Schaff HV. Influence of clinical and hemody-namic variables on risk of supraventricular tachycardia after coronary artery bypass. J Thorac Cardiovasc Surg 1991;101:56-65.
7. Frost L, Mølgaard H, Christiansen EH, et al. Atrial fibrillation and flutter after coronary artery bypass surgery: epidemiology, risk factors and preventative trials. Int J Cardiol 1992;36:253-61.
8. Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery: current trends and impact of hospital resources. Circulation 1996;94:390-7.
9. Khaja F, Parker JO. Hemodynamic effects of cardioversion in chronic atrial fibrillation. Arch Intern Med 1972;129:433-40.
10. Wong DT, Cheng DCH, Kustra R, et al. Risk factors of delayed extubation, prolonged length of stay in the intensive care unit, and mortality in patients undergoing CABG with fast track cardiac anesthesia: a new cardiac risk score. Anesthesiology 1999;91:936-44.
11. Mitchell LB. Incidence, timing and outcome of atrial tachyarrhythmias after cardiac surgery. In: Steinberg JS, ed. Atrial Fibrillation After Cardiac Surgery. Kluwer Academic Publishers 2000:37-50.
12. Abel RM, van Gelder HM, Pores IH, et al. Continued propranolol administration following coronary bypass surgery: antiarrhythmic effects. Arch Surg 1983;118:727-31.
13. Silverman NA, Wright R, Levitsky S. Efficacy of low-dose propranolol in preventing postoperative supraventricular tachyarrhythmias. Ann Surg 1982;196:194-7.
14. Kannell WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham Study. N Engl J Med 1982;306:1018-22.
15. Caretta Q, Mercanti CA, De Nardo D, et al. Ventricular conduction defects after coronary artery bypass grafting: multivariate analysis of preoperative, intra-operative and postoperative variables. Eur Heart J 1991; 12:1107-11.
16. Roffman JA, Feldman A. Digoxin and propranolol in the prophylaxis of supraventricular tachydysrhythmias after coronary bypass surgery. Ann Thorac Surg 1981;31:496-501.
17. Ormerod OJM, McGregor CGA, Stone DL, Wisbey C, Petch MC. Arrhythmias after coronary bypass surgery. Br Heart J 1984;51:618-21.
18. Orlando JR, van Herick R, Aronow WS, Olson HJ. Hemodynamics and echocardiograms before and after cardioversion of atrial fibrillation to normal sinus rhythm. Chest 1979;76:521-6.
19. Stanley TO, Mackensen GB, Grocott HP, et al; Neurological Outcome Research Group, CARE Investigators of the Duke Heart Center. The impact of post-operative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery. Anesth Analg 2002;94:290-5.
20. Taylor GJ, Malik SA, Colliver JA, et al. Usefulness of atrial fibrillation as a predictor of stroke after isolated coronary artery bypass grafting. Am J Cardiol 1987;60:905-7.
21. Lynn GM, Stefanko K, Reed JF III, Gee W, Nicholas G. Risk factors for stroke after coronary artery bypass. J Thorac Cardiovasc Surg 1992;104:1518-23.
22. Coplen SE, Antman EM, Berlin JA. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a meta-analysis of randomized control trials. Circulation 1990;82:1106-16.
23. Flaker GC, Blackshear JL, McBride R, et al. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992;20: 527-32.
24. Kowey PR, Stanowski A, Schnoor E. Impact of atrial fibrillation on duration of hospital stay and cost of coronary artery bypass surgery. Clin Res 1992;40A:365.
25. Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur Heart J 2006;27:2846-57.
26. Merritt JC, Niebauer M, Tarakji K, Hammer D, Mills RM. Comparison of effectiveness of carvedilol versus metoprolol or atenolol for atrial fibrillation appearing after coronary artery bypass grafting or cardiac valve operation. Am J Cardiol 2003;92:735-6.
27. Connolly SJ, Cybulski I, LamyA, et al. Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the β-Blocker Length of Stay (BLOS) study. Am Heart J 2003;145:226-32.
28. Crystal E, Thorpe KE, Connolly SJ, et al. Metoprolol prophylaxis increases length of hospital stay in patients not on pre-operative β blockers: the β-Blocker Length of Stay (BLOS) study. Heart 2004;90:941-2.
29. Bagshaw SM, Galbraith PD, Mitchell LB, et al. Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. Ann Thorac Surg 2006;82:1927-37.
30. Buckley MS, Nolan PE, Slack MK, et al. Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation. Pharmacotherapy 2007;27:360-8.
31. Solomon AJ, Greenberg MD, Kilborn MJ, Katz NM. Amiodarone versus a β-blocker to prevent atrial fibrillation after cardiovascular surgery. Am Heart J 2001;142:811-5.
32. Mooss AN, Wurdeman RL, Sugimoto JT, et al. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial. Am Heart J 2004;148:641-48.
33. Henyan NH, Gillespie EL, White CM, Kluger J, Coleman CI. Impact of intravenous magnesium on post-cardiothoracic surgery atrial fibrillation and length of hospital stay: a meta-analysis. Ann Thorac Surg 2005;80: 2402-6.
34. Solomon AJ, Berger AK, Trivedi KK, Hannan RL, Katz NM. The combination of propranol and magnesium does not prevent postoperative atrial fibrillation. Ann Thorac Surg 2000;69:126-9.
35. Bert AA, Reinert SE, Singh AK. A β-blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2001;15:204-9.
36. Forlani S, De Paulis R, de Notaris S, et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2002;74:720-6.
37. White CM, Caron MF, Kalus JS, et al. Atrial Fibrillation Suppression Trial II Investigators. Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent postcardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II (AFIST II). Circulation 2003;108(Suppl II):II-200-6.
38. Kowey PR, Stebbins D, Igidbashian L, et al. Clinical outcome of patients who develop PAF after CABG surgery. PACE 2001;24:191-3.
39. Lee JK, Klein GJ, Krahn AD, et al. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study. Am Heart J 2000;140:871-7.
40. Danias PG, Caulfield TA, Weigner MJ, et al. Likelihood of spontaneous conversion of AF to sinus rhythm. J Am Coll Cardiol 1998;31:588-92.
41. Meurin P, Weber H, Renaud N, et al. Evolution of the postoperative pericardial effusion after day 15: the problem of late tamponade. Chest 2004;125:2182-7.
42. VanderLugt JT, Mattioni T, Denker S, et al. Efficacy and safety of ibuti-lide fumarate for the conversion of atrial arrhythmias after cardiac surgery. Circulation 1999;100:369-75.
43. Solomon AF, Kouretas PC, Hopkins RA, et al. Early discharge of patients with new-onset atrial fibrillation after cardiovascular surgery. Am Heart J 1998;135:557-63.
44. Mitchell LB, Exner DV, Wyse DG, et al. Prophylactic oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, valve replacement, or repair (PAPABEAR): a randomized clinical trial. JAMA 2005;294:3093-100.
45. Toramen F, Karabulut EH, Alhan HC, Daǧdelen S, Tarcan S. Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass surgery. Ann Thorac Surg 2001;72,1256-62.
46. Greenberg MD, Katz NM, Iuliano S, Tempestra BJ, Solomon AJ. Atrial pacing for the prevention of atrial fibrillation after cardiovascular surgery. J Am Coll Cardiol 2000;35:1416-22.